D
MediPharm Labs Corp. MEDIF
$0.0573 $0.00183.24% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue 12.56% 24.86% 30.89% 31.70% 57.30%
Total Other Revenue -- -- -- -- --
Total Revenue 12.56% 24.86% 30.89% 31.70% 57.30%
Cost of Revenue 12.52% 24.11% 4.28% -20.95% -0.90%
Gross Profit 12.64% 26.45% 134.35% 3,360.60% 1,389.91%
SG&A Expenses -17.43% 3.08% -9.99% -2.94% 11.50%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -214.41% -128.34% -45.45% -137.78% -82.07%
Total Operating Expenses -2.47% 13.18% -2.87% -14.16% 3.36%
Operating Income 50.56% 21.63% 59.69% 71.60% 50.71%
Income Before Tax 47.34% 20.92% 24.96% 31.41% 47.28%
Income Tax Expenses -- -- -2,940.91% -4,511.36% -4,511.36%
Earnings from Continuing Operations 46.28% 19.27% 26.62% 32.77% 48.31%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 46.28% 19.27% 26.62% 32.77% 48.31%
EBIT 50.56% 21.63% 59.69% 71.60% 50.71%
EBITDA 59.52% 29.08% 70.80% 81.59% 57.72%
EPS Basic 48.44% 29.41% 39.66% 51.08% 62.74%
Normalized Basic EPS 53.68% 32.17% 68.05% 78.01% 65.04%
EPS Diluted 48.44% 29.41% 39.66% 51.08% 62.74%
Normalized Diluted EPS 53.68% 32.17% 68.05% 78.01% 65.04%
Average Basic Shares Outstanding 4.76% 13.18% 17.57% 29.43% 38.08%
Average Diluted Shares Outstanding 4.76% 13.18% 17.57% 29.43% 38.08%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --